My Research – Session 2: Adherence Interventions

Session 2 (Wednesday 24th February at 7pm GMT) –  CLICK HERE to REGISTER

 

We would like to invite you to join our monthly ‘My Research’ sessions. These sessions are delivered by members that have undertaken an audit or evaluation. They will spend 10 minutes describing their career pathway and the next 10 minutes about the research methods that they used. There will be time for detailed questions following the talk. These sessions will enable members to learn about quantitative and qualitative methods and the learning may guide and help you in your future projects. We also hope that this will be a good opportunity to learn about different career pathways in cancer pharmacy.

 

The second session will be delivered by: Nick Duncan and Andrea Preston

 

Biography (Nick Duncan) – Nick is an Academic Practitioner in the School of Pharmacy at the University of Birmingham and Consultant Haematology Pharmacist at University Hospitals Birmingham NHS Foundation Trust, UK. He qualified as a pharmacist in 1994 and has spent most of his career to date working in oncology and haematology, particularly in the area of haematopoietic stem cell transplantation. He qualified as an independent prescriber in 2010 and has an active prescribing role in a variety of haematology clinics. Areas of research interest include medicines adherence, chronic myeloid leukaemia and antifungal stewardship.

 

 

 

 

Biography (Andrea Preston) – Andrea is the Divisional Lead Pharmacist for Haematology at University Hospitals Bristol NHS Foundation Trust and part time Cancer Commissioning Pharmacist for NHSE South. She studied pharmacy at Cardiff University and qualified in 1999. The majority of her career has been in cancer services. In her clinical role she is proud to work within an excellent team of cancer pharmacists delivering specialist pharmacy services to oncology and haematology including BMT and CAR-T. She is an independent prescriber in multiple myeloma and amyloidosis. Her special interest in pharmacy research started after completing an MSc in Clinical Oncology at University of Birmingham, where she met and started collaborating with Nick Duncan. Special areas of research interest include dosing of systemic anticancer therapy (SACT) in obesity, adherence and use of technology to improve safety of SACT.

 

 

 

 

 

 

Please Note:

 

-Webinars will start at 19:00 GMT and will last about 30 minutes to 1 hour

-The Zoom link for the webinar will be sent on the day before the event

-Webinars are FREE to access for BOPA Paid Members

-Webinars will be recorded and appear in the BOPA eLearning section of the website via this link: https://www.bopa.org.uk/course-category/audit-and-research/

-Webinars will be on a monthly basis

 

Pinkie, Bastiaan and Alkesh
BOPA Audit & Research and Education &Training Sub-Committee Chairs

 

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article